{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:49:57Z","timestamp":1791859797759,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.bbr.2008.10.010","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T09:04:51Z","timestamp":1224147891000},"page":"398-403","source":"Crossref","is-referenced-by-count":92,"title":["Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease"],"prefix":"10.1016","volume":"197","author":[{"given":"Pramod","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder K.","family":"Kaundal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2008.10.010_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nlm.2004.06.006","article-title":"Is the unilateral lesion of the left substantia nigra pars compacta sufficient to induce working memory impairment in rats?","volume":"82","author":"Bellissimo","year":"2004","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.bbr.2008.10.010_bib2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0006-2952(02)01174-7","article-title":"Glutathione, iron and Parkinson's disease","volume":"64","author":"Bharath","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbr.2008.10.010_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp.2005.077495","article-title":"PPARs: a new target for neuroprotection","volume":"77","author":"Bordet","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2008.10.010_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2002.00990.x","article-title":"Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease","volume":"82","author":"Breidert","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2008.10.010_bib5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/jnnp.2006.108076","article-title":"Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease","volume":"78","author":"Bronnick","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2008.10.010_bib6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1212\/01.wnl.0000306632.43729.24","article-title":"Dementia and survival in Parkinson disease: a 12-year population study","volume":"70","author":"Buter","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2008.10.010_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.nut.2007.05.004","article-title":"Antioxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice","volume":"23","author":"Chen","year":"2007","journal-title":"Nutrition"},{"key":"10.1016\/j.bbr.2008.10.010_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2005.11.049","article-title":"Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia\/reperfusion","volume":"530","author":"Collino","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2008.10.010_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1020736131907","article-title":"The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities","volume":"22","author":"Da Cunha","year":"2002","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.bbr.2008.10.010_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia","volume":"124","author":"Da Cunha","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2008.10.010_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1074-7427(03)00008-X","article-title":"Evidence for the substantia nigra pars compacta as an essential component of a memory system independent of the hippocampal memory system","volume":"79","author":"Da Cunha","year":"2003","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.bbr.2008.10.010_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.nlm.2006.12.004","article-title":"Pre-training to find a hidden platform in the Morris water maze can compensate for a deficit to find a cued platform in a rat model of Parkinson's disease","volume":"87","author":"Da Cunha","year":"2007","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.bbr.2008.10.010_bib13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2008.10.010_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1474-4422(03)00351-X","article-title":"Dementia associated with Parkinson's disease","volume":"2","author":"Emre","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bbr.2008.10.010_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ddmec.2004.11.016","article-title":"Parkinson's disease \u2013 molecular mechanisms of disease","volume":"1","author":"Eriksen","year":"2004","journal-title":"Drug Dis Today: Dis Mech"},{"key":"10.1016\/j.bbr.2008.10.010_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0100-879X2006005000053","article-title":"Neuroprotective effect of ketamine\/xylazine on two rat models of Parkinson's disease","volume":"40","author":"Ferro","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.bbr.2008.10.010_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"Ferro","year":"2005","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.bbr.2008.10.010_bib18","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/01.wnl.0000242630.52203.8f","article-title":"Clinical phenotype of Parkinson disease dementia","volume":"67","author":"Galvin","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2008.10.010_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0027-5107(95)00136-0","article-title":"PPAR: a mediator of peroxisome proliferator action","volume":"333","author":"Green","year":"1995","journal-title":"Mutat Res"},{"key":"10.1016\/j.bbr.2008.10.010_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ncpneuro0586","article-title":"Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders","volume":"3","author":"Heneka","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.bbr.2008.10.010_bib21","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1471-4159.2006.04327.x","article-title":"Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system","volume":"100","author":"Hunter","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2008.10.010_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neubiorev.2007.08.005","article-title":"Pathophysiology of the basal ganglia and movement disorders: from animal models to human clinical applications","volume":"32","author":"Israel","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2008.10.010_bib23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0301-0082(03)00085-6","article-title":"Dopamine: a potential substrate for synaptic plasticity and memory mechanisms","volume":"69","author":"Jay","year":"2003","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bbr.2008.10.010_bib24","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/mds.21144","article-title":"Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease: a community-based, longitudinal study","volume":"21","author":"Kurz","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2008.10.010_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.expneurol.2006.04.006","article-title":"PPARgamma agonists as new therapeutic agents for the treatment of Alzheimer's disease","volume":"199","author":"Landreth","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2008.10.010_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbr.2008.10.010_bib27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1152\/jn.1999.82.2.978","article-title":"Role of [corrected] nigrostriatal dopamine system in learning to perform sequential motor tasks in a predictive manner","volume":"82","author":"Matsumoto","year":"1999","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.bbr.2008.10.010_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0361-9230(02)00754-2","article-title":"Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions","volume":"58","author":"Miyoshi","year":"2002","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bbr.2008.10.010_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","article-title":"Peroxisome proliferator-activated receptors and inflammation","volume":"110","author":"Moraes","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bbr.2008.10.010_bib30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1517\/14656566.8.6.817","article-title":"Rivastigmine and Parkinson dementia complex","volume":"8","author":"Moretti","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bbr.2008.10.010_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","article-title":"Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver","volume":"582","author":"Moron","year":"1979","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbr.2008.10.010_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-0082(02)00011-4","article-title":"Dopamine and the regulation of cognition and attention","volume":"67","author":"Nieoullon","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bbr.2008.10.010_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bbr.2008.10.010_bib34","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.lfs.2006.07.018","article-title":"Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats","volume":"79","author":"Pathan","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2008.10.010_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2003.11.029","article-title":"Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats","volume":"484","author":"Perry","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2008.10.010_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/bjp.2008.78","article-title":"The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B","volume":"154","author":"Quinn","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2008.10.010_bib37","first-page":"2046","article-title":"Parkinson's disease: diagnosis and treatment","volume":"74","author":"Rao","year":"2006","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.bbr.2008.10.010_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.12.032","article-title":"The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats","volume":"560","author":"Reksidler","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2008.10.010_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pneurobio.2006.11.009","article-title":"Advances in the treatment of Parkinson's disease","volume":"81","author":"Singh","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bbr.2008.10.010_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson's disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.bbr.2008.10.010_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0361-9230(97)00452-8","article-title":"Cognitive changes in mice following moderate MPTP exposure","volume":"45","author":"Tanila","year":"1998","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bbr.2008.10.010_bib42","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson's disease cohort","volume":"130","author":"Williams-Gray","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2008.10.010_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jneuroim.2007.09.029","article-title":"Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-kappaB and JNK activation and suppression of COX-2 activity","volume":"192","author":"Xing","year":"2007","journal-title":"J Neuroimmunol"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432808005585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432808005585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T21:41:04Z","timestamp":1632001264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432808005585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0166432808005585"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2008.10.010","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}